F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business. This story matters for General News readers tracking general. Reported by nytimes.com. Read the full original at the source link below.
Originally reported by nytimes.com. NewsAvenue curates and briefs the general news stories that matter. Our editorial policy →